Ágnes Horváth

708 total citations
37 papers, 398 citations indexed

About

Ágnes Horváth is a scholar working on Rheumatology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Ágnes Horváth has authored 37 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 6 papers in Pathology and Forensic Medicine and 5 papers in Molecular Biology. Recurrent topics in Ágnes Horváth's work include Rheumatoid Arthritis Research and Therapies (10 papers), Spondyloarthritis Studies and Treatments (7 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Ágnes Horváth is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (10 papers), Spondyloarthritis Studies and Treatments (7 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Ágnes Horváth collaborates with scholars based in Hungary, United States and Ireland. Ágnes Horváth's co-authors include Zoltán Szekanecz, Gabriella Szűcs, Szilvia Szamosi, Sándor Szántó, Harjit Pal Bhattoa, Judit M. Veres, Éva Csibri, Mária Tünde Magyar, Péter Rajna and Béla Clemens and has published in prestigious journals such as Journal of Hepatology, Annals of the Rheumatic Diseases and Molecules.

In The Last Decade

Ágnes Horváth

31 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ágnes Horváth Hungary 11 102 95 68 65 61 37 398
Gérard Greig Switzerland 8 40 0.4× 65 0.7× 40 0.6× 45 0.7× 17 0.3× 20 483
Carolina Moreno Portugal 13 18 0.2× 141 1.5× 46 0.7× 115 1.8× 18 0.3× 48 490
David K. Li Canada 7 70 0.7× 169 1.8× 14 0.2× 38 0.6× 19 0.3× 9 332
B. Schlüter Germany 13 80 0.8× 21 0.2× 43 0.6× 42 0.6× 13 0.2× 46 471
Kishan Patel United States 11 46 0.5× 71 0.7× 18 0.3× 15 0.2× 28 0.5× 43 372
Ridha Mrissa Tunisia 12 135 1.3× 61 0.6× 5 0.1× 58 0.9× 47 0.8× 64 471
Irene Azzolin Italy 4 186 1.8× 31 0.3× 8 0.1× 25 0.4× 15 0.2× 8 371
Jun Nakamura Japan 12 43 0.4× 13 0.1× 16 0.2× 232 3.6× 33 0.5× 49 525
Harald Siedentop Germany 10 43 0.4× 29 0.3× 28 0.4× 35 0.5× 8 0.1× 14 429
Shaul Kadosh United States 6 111 1.1× 333 3.5× 8 0.1× 25 0.4× 16 0.3× 11 430

Countries citing papers authored by Ágnes Horváth

Since Specialization
Citations

This map shows the geographic impact of Ágnes Horváth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ágnes Horváth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ágnes Horváth more than expected).

Fields of papers citing papers by Ágnes Horváth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ágnes Horváth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ágnes Horváth. The network helps show where Ágnes Horváth may publish in the future.

Co-authorship network of co-authors of Ágnes Horváth

This figure shows the co-authorship network connecting the top 25 collaborators of Ágnes Horváth. A scholar is included among the top collaborators of Ágnes Horváth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ágnes Horváth. Ágnes Horváth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kerekes, György, Attila Hamar, Gábor Tajti, et al.. (2023). Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis. Lara D. Veeken. 62(SI3). SI304–SI312. 6 indexed citations
2.
Horváth, Ágnes, Edit Végh, Boglárka Soós, et al.. (2023). Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis. Frontiers in Medicine. 10. 1226760–1226760.
3.
4.
Végh, Edit, Ágnes Horváth, Attila Hamar, et al.. (2021). Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology. Biomolecules. 11(10). 1535–1535. 10 indexed citations
5.
Kormányos, Árpád, et al.. (2021). Left Ventricular Rotational Abnormalities in Treated Hypopituitarism: Insights From the Three-Dimensional Speckle-Tracking Echocardiographic MAGYAR-Path Study. Frontiers in Cardiovascular Medicine. 8. 703146–703146. 2 indexed citations
6.
7.
Horváth, Ágnes, Gyula Schneider, Mihály Szécsi, et al.. (2019). Synthesis, Biological Evaluation and Docking Studies of 13-Epimeric 10-fluoro- and 10-Chloroestra-1,4-dien-3-ones as Potential Aromatase Inhibitors. Molecules. 24(9). 1783–1783. 9 indexed citations
8.
Horváth, Ágnes, Edit Végh, Attila Hamar, et al.. (2019). Complex assessment of bone mineral density, fracture risk, vitamin D status, and bone metabolism in Hungarian systemic sclerosis patients. Arthritis Research & Therapy. 21(1). 274–274. 15 indexed citations
9.
Horváth, Ágnes, et al.. (2018). Laser-induced plasma spectroscopy (LIPS): use of a geological tool in assessing bone mineral content. Lasers in Medical Science. 33(6). 1225–1236. 1 indexed citations
10.
Szentpétery, Ágnes, Ágnes Horváth, Harjit Pal Bhattoa, et al.. (2017). Effects of targeted therapies on the bone in arthritides. Autoimmunity Reviews. 16(3). 313–320. 39 indexed citations
11.
Juhász, Balázs, Ágnes Horváth, Zoltán Pethő, et al.. (2016). Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls. Osteoporosis International. 28(4). 1271–1277. 10 indexed citations
12.
Pethő, Zoltán, et al.. (2015). Vitamin D status in men with psoriatic arthritis: a case-control study. Osteoporosis International. 26(7). 1965–1970. 17 indexed citations
13.
Horváth, Ágnes, Andrea Váncsa, É. Végh, et al.. (2015). A4.3 Effects of anti-TNF therapy on markers of bone homeostasis in rheumatoid arthritis and ankylosing spondylitis. Annals of the Rheumatic Diseases. 74. A37–A37. 3 indexed citations
14.
Bodnár, Nóra, Szilvia Szamosi, Ágnes Horváth, et al.. (2014). Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis. The European Journal of Health Economics. 15(S1). 93–100. 26 indexed citations
15.
Szekanecz, Éva, Szilvia Szamosi, Ágnes Horváth, et al.. (2012). Malignancies associated with systemic sclerosis. Autoimmunity Reviews. 11(12). 852–855. 44 indexed citations
16.
Bárdi, Edit, et al.. (2012). Anthracycline Causes Impaired Vascular Endothelial Function and Aortic Stiffness in Long Term Survivors of Childhood Cancer. Pathology & Oncology Research. 19(3). 375–383. 43 indexed citations
17.
Horváth, Ágnes, Tímea Csák, Andrzej Habior, et al.. (2004). NOD2/CARD15 SNP8, 12 and 13 and other EXON4 mutations and primary biliary cirrhosis (PBC) in Hungarian and Polish patients. Zeitschrift für Gastroenterologie. 42(5). 2 indexed citations
18.
Sárdy, Miklós, et al.. (2000). Comparison of a tissue transglutaminase ELISA with the endomysium antibody test in the diagnosis of gluten-sensitive enteropathy. Zeitschrift für Gastroenterologie. 38(5). 357–364. 18 indexed citations
19.
Rajna, Péter, Béla Clemens, Éva Csibri, et al.. (1997). Hungarian multicentre epidemiologic study of the warning and initial symptoms (prodrome, aura) of epileptic seizures. Seizure. 6(5). 361–368. 85 indexed citations
20.
Smith, Stephen D., Charles M. Rubin, Ágnes Horváth, & James B. Nachman. (1990). Non-Hodgkin's lymphoma in children.. PubMed. 17(1). 113–9. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gérard Greig Breakdown of academic impact, for papers by Carolina Moreno Breakdown of academic impact, for papers by David K. Li Breakdown of academic impact, for papers by B. Schlüter Breakdown of academic impact, for papers by Kishan Patel Breakdown of academic impact, for papers by Ridha Mrissa Breakdown of academic impact, for papers by Irene Azzolin Breakdown of academic impact, for papers by Jun Nakamura Breakdown of academic impact, for papers by Harald Siedentop Breakdown of academic impact, for papers by Shaul Kadosh
Rankless by CCL
2026